Lung volume reduction eligibility in patients with COPD completing pulmonary rehabilitation: results from the UK National Asthma and COPD Audit Programme
Lung volume reduction eligibility in patients with COPD completing pulmonary rehabilitation: results from the UK National Asthma and COPD Audit Programme
Objectives: to establish what proportion of patients completing a UK pulmonary rehabilitation (PR) programme meet the 2018 National Institute for Health and Care Excellence (NICE) chronic obstructive pulmonary disease (COPD) guideline (NG115) criteria to have a respiratory review to establish whether referral to a lung volume reduction multidisciplinary team would be appropriate. This respiratory review would include evaluation of the presence of hyperinflation and the presence of emphysema on CT scan. The NICE criteria include measures of breathlessness and exercise capacity but these parameters are not completely defined.
Design: observational study.
Setting: PR programmes across the UK in 2015 (210 centres) and 2017 (184 centres) entering data into the Royal College of Physicians’ National Asthma and COPD Audit Programme.
Participants: 8295 (55.7%) of 14 889 patients in programmes using incremental shuttle walk test (ISWT) or 6-minute walk test (6MWT) as an outcome measure completed PR, and 4856 (32.6%) had complete data recorded (6MWT/ISWT, baseline spirometry, Medical Research Council (MRC) dyspnoea score).
Results: depending on the walking test safety threshold adopted for the ISWT (≥140 m or ≥ 80 m) and the MRC dyspnoea score threshold used (MRC score ≥3 or ≥4 at the end of PR), between 4.9% and 18.1% of PR completers met the NICE criteria for a lung volume reduction-focused respiratory review.
Conclusions: lung volume reduction therapies are beneficial in appropriately selected patients with COPD, but few procedures are performed, and treatment pathways are unclear. These data help to inform the feasibility of the approach recommended by NICE and highlight the need for future systematic pathways to reduce inequalities in patients being considered for effective treatments
Buttery, Sara C.
a93f2fbc-4c73-4b9d-82c0-95a19a8b6aa0
Lewis, Adam
71c83b66-d847-4aee-b716-b04d6de51450
Kemp, Samuel V.
9dd165a6-b64d-4910-b043-d2f4d44ecbb4
Banya, Winston
3a658917-e227-423f-84b7-cc898c0cb9f7
Quint, Jennifer K.
22800655-8987-4464-8385-7f08860c92f9
Steiner, Michael C.
ecb02779-579c-48df-911d-cb0d992a2a85
Hopkinson, Nicholas S.
91e9a2af-8ab3-4671-b766-761e82bd5310
Buttery, Sara C.
a93f2fbc-4c73-4b9d-82c0-95a19a8b6aa0
Lewis, Adam
71c83b66-d847-4aee-b716-b04d6de51450
Kemp, Samuel V.
9dd165a6-b64d-4910-b043-d2f4d44ecbb4
Banya, Winston
3a658917-e227-423f-84b7-cc898c0cb9f7
Quint, Jennifer K.
22800655-8987-4464-8385-7f08860c92f9
Steiner, Michael C.
ecb02779-579c-48df-911d-cb0d992a2a85
Hopkinson, Nicholas S.
91e9a2af-8ab3-4671-b766-761e82bd5310
Buttery, Sara C., Lewis, Adam, Kemp, Samuel V., Banya, Winston, Quint, Jennifer K., Steiner, Michael C. and Hopkinson, Nicholas S.
(2020)
Lung volume reduction eligibility in patients with COPD completing pulmonary rehabilitation: results from the UK National Asthma and COPD Audit Programme.
BMJ Open, 10, [e040942].
(doi:10.1136/bmjopen-2020-040942).
Abstract
Objectives: to establish what proportion of patients completing a UK pulmonary rehabilitation (PR) programme meet the 2018 National Institute for Health and Care Excellence (NICE) chronic obstructive pulmonary disease (COPD) guideline (NG115) criteria to have a respiratory review to establish whether referral to a lung volume reduction multidisciplinary team would be appropriate. This respiratory review would include evaluation of the presence of hyperinflation and the presence of emphysema on CT scan. The NICE criteria include measures of breathlessness and exercise capacity but these parameters are not completely defined.
Design: observational study.
Setting: PR programmes across the UK in 2015 (210 centres) and 2017 (184 centres) entering data into the Royal College of Physicians’ National Asthma and COPD Audit Programme.
Participants: 8295 (55.7%) of 14 889 patients in programmes using incremental shuttle walk test (ISWT) or 6-minute walk test (6MWT) as an outcome measure completed PR, and 4856 (32.6%) had complete data recorded (6MWT/ISWT, baseline spirometry, Medical Research Council (MRC) dyspnoea score).
Results: depending on the walking test safety threshold adopted for the ISWT (≥140 m or ≥ 80 m) and the MRC dyspnoea score threshold used (MRC score ≥3 or ≥4 at the end of PR), between 4.9% and 18.1% of PR completers met the NICE criteria for a lung volume reduction-focused respiratory review.
Conclusions: lung volume reduction therapies are beneficial in appropriately selected patients with COPD, but few procedures are performed, and treatment pathways are unclear. These data help to inform the feasibility of the approach recommended by NICE and highlight the need for future systematic pathways to reduce inequalities in patients being considered for effective treatments
Text
e040942.full
- Version of Record
More information
Accepted/In Press date: 18 October 2020
e-pub ahead of print date: 27 November 2020
Identifiers
Local EPrints ID: 488825
URI: http://eprints.soton.ac.uk/id/eprint/488825
ISSN: 2044-6055
PURE UUID: d10d2d61-07b4-4da7-ae10-27efca5024ad
Catalogue record
Date deposited: 05 Apr 2024 16:46
Last modified: 10 Apr 2024 02:14
Export record
Altmetrics
Contributors
Author:
Sara C. Buttery
Author:
Adam Lewis
Author:
Samuel V. Kemp
Author:
Winston Banya
Author:
Jennifer K. Quint
Author:
Michael C. Steiner
Author:
Nicholas S. Hopkinson
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics